Skip to content
  • About
    • Supporter
    • Expert Index
    • Editorial Board
    • Editorial Team
    • Editorial Policy
  • Contact
  • Sign up

Visit

vjdementia
VJNeurology
Logo
  • Home (current)
  • Diseases
    Parkinson's Disease
    Multiple Sclerosis and Related Disorders
    Headache
    Amyotrophic Lateral Sclerosis
    Epilepsy
    Sleep Disorders
    Stroke
    Neuromuscular Disorders
    Movement Disorders
    View all Diseases
  • Topics
    Biology
    Diagnostics
    Trial Updates
    Treatment
    Prevention
    Surgery
    Imaging
    Genetics
    COVID-19
    View all Topics
  • Conferences
    CONy 2023
    ACTRIMS 2023
    ISC 2023
    EHC 2022
    AES 2022
    WSC 2022
    View all Conferences
  • Features
  • Podcasts
    • About
      • Supporter
      • Expert Index
      • Editorial Board
      • Editorial Team
      • Editorial Policy
    • Contact
    • Sign up

Bernhard Steinhoff

Insights from cenobamate studies 1:16
Insights from cenobamate studies
Bernhard Steinhoff • 27 Jun 2022
Concomitant ASM dose reductions in clinical trial of adjunctive cenobamate for focal seizures 1:11
Concomitant ASM dose reductions in clinical trial of adjunctive cenobamate for focal seizures
Bernhard Steinhoff • 27 Jun 2022
The burden of epilepsy in different age groups 1:18
The burden of epilepsy in different age groups
Bernhard Steinhoff • 27 Jun 2022
An analysis of COVID-19 infection and vaccinations in epilepsy patients 1:04
An analysis of COVID-19 infection and vaccinations in epilepsy patients
Bernhard Steinhoff • 27 Jun 2022
Discontinuation of anti-seizure medication in seizure-free epilepsy patients 1:15
Discontinuation of anti-seizure medication in seizure-free epilepsy patients
Bernhard Steinhoff • 27 Jun 2022
Cenobamate efficacy occurs early during titration 1:37
Cenobamate efficacy occurs early during titration
Bernhard Steinhoff • 4 Jun 2021
The future of drug-resistant epilepsy management 2:08
The future of drug-resistant epilepsy management
Bernhard Steinhoff • 4 Jun 2021
What is behind cenobamate’s remarkable efficacy against focal-onset seizures? 1:59
What is behind cenobamate’s remarkable efficacy against focal-onset seizures?
Bernhard Steinhoff • 4 Jun 2021
Personalized treatment approaches in epilepsy 1:53
Personalized treatment approaches in epilepsy
Bernhard Steinhoff • 4 Jun 2021
Journal Pages
  • Diseases
  • Topics
  • Medicines
  • Trials
  • Conferences
  • Features
Newsletter

Receive the latest news and videos from VJNeurology via email

Sign up
Contact Us

Contact us for more information

mmp logo

Magdalen Centre
The Oxford Science Park
Oxford OX4 4GA, United Kingdom

VJNeurology logo
The content of VJNeurology is intended for healthcare professionals
  • Cookie Policy
  • Privacy Policy
  • Terms of Use
  • Editorial Policy